ARCHIVES

MET Inhibitor Improved Time To Progression by 56 Percent

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

NCAB Approves OIA Awards For At Least 21 Scientist, More If Payline Lifted

May 24, 1985

Texas Oncology Designated Aranesp As Preferred Treatment

December 13, 2002

NCI Deputy Barker Hits FDA, Calls for New Incentives for Pharmaceutical Industry; Barker Co-Founded Dietary Supplements Firm

May 30, 2003

ASCO President Swain: “Shattering Impact on Cancer Enterprise”

February 15, 2013

In Brief: CDP Awarded Contract To Do Facilities Survey; MIHICH Appointment Official; Kraybill Retires

August 24, 1984

IMRT Usage and Cost Related to Geography And Medicare Reimbursement Policy, Study Finds

April 29, 2011